Manufacture of pharmaceutical preparations
TAFRE AS
Revenue 2024
NOK 8.3m
Operating profit
NOK 1.1m
Equity
NOK 2.3m
Incorporated
2014
Employees
5
Share capital
NOK 100,000
Financials
Total operating revenue
Operating profit (EBIT)
Income statement
| Post | 2024 | Trend |
|---|---|---|
| Total operating revenue | 8.3m | |
| Total operating costs | 7.2m | |
| Operating profit (EBIT) | 1.1m | |
| Net financial items | −59k | |
| Profit for the year | 829k |
Balance sheet
| Post | 2024 | Trend |
|---|---|---|
| Total assets | 4.6m | |
| of which current assets | 4.6m | |
| Equity | 2.3m | |
| Total liabilities | 2.3m |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.